MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.lfs.2026.124467

Медицинская библиотека · Life sciences · 2026

Advanced glycation end product (AGE)-modified albumin does not enhance neutrophil extracellular trap formation and minimally impacts endothelial inflammation in large vessels.

Junho Carolina Victoria Cruz, Dai Yusang, Schieren Luisa, Hourtz Sina, Rykova Tetiana, Vondenhoff Sonja, Wessiepe Martina, Zou Jinmi, Jankowski Joachim, Goettsch Claudia, Noels Heidi

СтатьяПеревод пока не подготовлен

Аннотация

AIMS: Advanced glycation end products (AGEs), particularly AGE-modified albumin (AGE-BSA), have been implicated in vascular inflammation and endothelial dysfunction, while neutrophil extracellular traps (NETs) are known to aggravate endothelial injury. Here, we investigated whether AGE-BSA directly promotes endothelial inflammatory and thrombotic activation, modulates neutrophil oxidative stress and NET formation, and may enhance NET-induced endothelial inflammation.

MATERIALS, METHODS, AND KEY FINDINGS: In human aortic and human umbilical vein endothelial cells, two different endotoxin-free AGE-BSA formulations did not or only minimally alter the expression or secretion of inflammatory (IL-6, IL-1β, CCL2) or thrombotic (VCAM-1, tissue factor) markers. In parallel, neutrophils from healthy donors were exposed to BSA or AGE-BSA, and neither basal nor PMA-stimulated NET formation nor reactive oxygen species (ROS) production were affected. Furthermore, endothelial cells stimulated with PMA-induced NETs generated in the presence of BSA or AGE-BSA showed comparable induction of inflammatory and pro-thrombotic genes, indicating that AGE-BSA does not modify NET-mediated endothelial activation. Flow cytometry revealed higher intracellular than surface RAGE levels in endothelial cells and a low surface expression in neutrophils, potentially limiting AGE-RAGE signaling at the plasma membrane.

SIGNIFICANCE: Collectively, these data demonstrate that, under the conditions tested, endotoxin-free AGE-BSA has no or minimal pro-inflammatory effect on human aortic or umbilical vein endothelial cells, neutrophil NET and ROS formation, nor NET-driven endothelial inflammation, potentially due to a limited surface RAGE availability or downstream signaling capacity. This challenges the view of an inherent pro-inflammatory effect of AGE-modified BSA and highlights the significance of important cell type- and context-specific contributors.

Для цитирования: Junho Carolina Victoria Cruz, Dai Yusang, Schieren Luisa, Hourtz Sina, Rykova Tetiana, Vondenhoff Sonja, Wessiepe Martina, Zou Jinmi, Jankowski Joachim, Goettsch Claudia, Noels Heidi. Advanced glycation end product (AGE)-modified albumin does not enhance neutrophil extracellular trap formation and minimally impacts endothelial inflammation in large vessels.. Life sciences. 2026. DOI: 10.1016/j.lfs.2026.124467.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.